大麻使用障碍与其他物质使用特质的遗传影响及因果通路
该研究利用大麻使用障碍(CanUD)的新基因组学数据,进行遗传相关、基因组结构方程模型(genomicSEM)和孟德尔随机化(MR)分析,发现CanUD与多种物质使用障碍存在显著因果效应和双向关系,且CanUD与大麻使用负荷于不同遗传因子。
要点
- CanUD对阿片使用障碍、问题性饮酒、饮酒量、尼古丁依赖、吸烟启动等均有显著因果效应。
- 阿片使用障碍、问题性饮酒、吸烟启动、戒烟和饮酒量均增加CanUD风险,呈双向性。
- 大麻使用与问题性饮酒、吸烟启动、饮酒量双向相关,并增加阿片使用障碍风险。
核心结论
- CanUD和大麻使用均可增加其他物质使用障碍的风险,大麻合法化可能增加其他问题性物质使用。
研究设计与样本
- 利用CanUD基因组学数据进行遗传相关、基因组结构方程模型(genomicSEM)和孟德尔随机化(MR)分析。
主要发现
- CanUD对阿片使用障碍的IVW β=0.925±0.082,对问题性饮酒的IVW β=0.443±0.030。
- CanUD对每周饮酒量的IVW β=0.182±0.025,对FTND的IVW β=0.183±0.052。
- CanUD对每日吸烟量的IVW β=0.150±0.045,对当前与既往吸烟者的IVW β=0.178±0.052。
- CanUD对吸烟启动的IVW β=0.405±0.042,大麻使用对阿片使用障碍的IVW β=0.785±0.266。
- genomicSEM确认CanUD和大麻使用负荷于不同遗传因子。
关键数值与推荐
- 阿片使用障碍、问题性饮酒、吸烟启动、戒烟和每周饮酒量均增加CanUD风险。
- 大麻使用与问题性饮酒、吸烟启动和每周饮酒量存在双向关系。
临床怎么用
- 临床应关注CanUD患者其他物质使用障碍的筛查与预防。
- 大麻合法化背景下需警惕其他问题性物质使用的增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cannabis use disorder (CanUD) has increased with the legalization of the use of cannabis. Around 20% of individuals using cannabis develop CanUD, and the number of users has grown with increasing ease of access. CanUD and other substance use disorders (SUDs) are associated phenotypically and genetically. We leveraged new CanUD genomics data to undertake genetically-informed analyses with unprecedented power, to investigate the genetic architecture and causal relationships between CanUD and lifetime cannabis use with risk for developing SUDs and substance use traits. Analyses included calculating local and global genetic correlations, genomic structural equation modeling (genomicSEM), and Mendelian Randomization (MR). Results from the genetic correlation and genomicSEM analyses demonstrated that CanUD and cannabis use differ in their relationships with SUDs and substance use traits. We found significant causal effects of CanUD influencing all the analyzed traits: opioid use disorder (OUD) (Inverse variant weighted, IVW β = 0.925 ± 0.082), problematic alcohol use (PAU) (IVW β = 0.443 ± 0.030), drinks per week (DPW) (IVW β = 0.182 ± 0.025), Fagerström Test for Nicotine Dependence (FTND) (IVW β = 0.183 ± 0.052), cigarettes per day (IVW β = 0.150 ± 0.045), current versus former smokers (IVW β = 0.178 ± 0.052), and smoking initiation (IVW β = 0.405 ± 0.042). We also found evidence of bidirectionality showing that OUD, PAU, smoking initiation, smoking cessation, and DPW all increase risk of developing CanUD. For cannabis use, bidirectional relationships were inferred with PAU, smoking initiation, and DPW; cannabis use was also associated with a higher risk of developing OUD (IVW β = 0.785 ± 0.266). GenomicSEM confirmed that CanUD and cannabis use load onto different genetic factors. We conclude that CanUD and cannabis use can increase the risk of developing other SUDs. This has substantial public health implications; the move towards legalization of cannabis use may be expected to increase other kinds of problematic substance use. These harmful outcomes are in addition to the medical harms associated directly with CanUD.
引用
- Galimberti M, Levey DF, Deak JD, et al. Genetic influences and causal pathways shared between cannabis use disorder and other substance use traits. Mol Psychiatry. 2024. PMID: 38580809. doi:10.1038/s41380-024-02548-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。